Undiagnosed Chronic Obstructive Pulmonary Disease amongst Coronary Artery Disease Patients: A single centre study
DOI:
https://doi.org/10.1996/pjcm.v28i4.879Keywords:
Coronary Artery Disease, Chronic Obstructive Airway Disease, PFTAbstract
Background: Chronic Obstructive Pulmonary Disease (COPD), a respiratory illness with persistent symptoms and limited airflow, is commonly caused by tobacco smoking and other factors. It is the world's fourth leading cause of death, and it could reach number three. COPD patients often have co-morbidities such as coronary artery disease (CAD), which complicates treatment and can lead to increased morbidity and mortality.Objective: This study aimed to determine the frequency of undiagnosed chronic obstructive pulmonary disease in individuals with coronary artery disease. Methodology: This cross-sectional study was carried out at the Department of Pulmonology and Cardiology, Timergara Teaching Hospital, Dir Lower from January 2020 to January 2021. A total of 160 participants diagnosed with CAD were included. We did not include patients who were unable to undergo spirometer testing (such as intubated, in shock, with active angina pain), nor did we consider those with a history of bronchial asthma or pulmonary edema. The COPD diagnosis was confirmed with FEV1/FVC having less than 70 percent. SPSS-15 was used for statistical purposes. We used frequencies and percentages for categorical variables such as gender, COPD. The SD for continuous variables, including age, was computed.Results: Out of 160 participants 58.1% were male and 41.8%. Female The study population's mean age was 57.97 ± 11.08 years. Out of 160 patients, 60 (37.7%) were diagnosed with COPD. Among the 60 patients of COPD, 41 (68.42%) were male and 19 (31.66%) were Female. Maximum figure of COPD individuals was in the age group between 66–80 years. Mean pre and post-bronchodilator values of FEV1 in COPD subjects were 58.65 and 60.82 respectively. COPD was categorized on the foundation of GOLD standards as eight individuals (13.3%) were in grade 1, twenty-eight participants (46.6%) were in grade 2, 19 patients (31.6%) were in grade three and five patients (8.3%) were in grade four of COPD. Among male individuals with COPD, 32 (78.0%) were smokers. Conclusion: Our study concludes that the frequency of COPD is high among patients with CAD. To determine the exact incidence of COPD in individuals with coronary artery disease, comprehensive multi-centric prospective studies need to be conducted which will provide a thorough explanation of the co-existence between these conditions.”References
Global Initiative for Chronic Obstructive Lung Disease (GOLD). The Global Strategy for the Diagnosis, Management and Prevention of COPD; 2017. Available from URL: http://goldcopd.org.
Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27(2):397-412.
Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014; 35(42):2929-59.
Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation. 2017;135(10):e146–603.
Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Vestbo J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065-72.
Maclay JD, Macnee W. Cardiovascular disease in COPD: mechanisms. Chest. 2013;143(3):798-807.
Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: a systematic literature review. Chest. 2013;144(4): 1163-78
Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Boyd C, et al. The prevalence of clinically relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med. 2012;12:26.
Soriano JB, Rigo F, Guerrero D, Yañez A, Forteza JF, Frontera G, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2010;137(2):333-40
Almagro P, Lapuente A, Pareja J, Yun S, Garcia ME, Padilla F, et al. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis. 2015;10:1353-61.
Zhang M, Cheng YJ, Zheng WP, Liu GH, Chen HS, Ning Y, et al. Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Biomed Res Int. 2016;2016:8212459-6.
Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Cardiovascular events in patients with COPD: TORCH study results. Thorax. 2010;65(8): 719-25.
Ait-Khaled N, Enarson D, Bousquet J. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bull World Health Organ. 2001;79(10):971-9
Tageldin MA, Nafti S, Khan JA, Nejjari C, Beji M, Mahboub B, et al. Distribution of COPD - related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106(Suppl 2):S25-32.
Al Omari M, Khassawneh BY, Khader Y, Dauod AS, Bergus G. Prevalence of chronic obstructive pulmonary disease among adult male cigarette smokers: a community-based study in Jordan. Int J Chron Obstruct Pulmon Dis. 2014;9:753-8.
Ahmed AH, Yagoub TE, Muthana F. Prevalence of chronic obstructive pulmonary disease in patients with catheter-diagnosed coronary artery disease. Ann Thorac Med. 2009;4(2):91-2.
Ullah R, Salam S, Ghaffar T, Muhammad R, Khan I. Frequency Of Undiagnosed Chronic Obstructive Pulmonary Disease In Patients With Coronary Artery Disease. J Ayub Med Coll Abbottabad. 2017;29 (2):285-8.
Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 1994;309(6959):901-11.
Higgins MW, Enright PL, Kronmal RA, Schenker MB, Anton-Culver H, Lyles M. Smoking and lung function in elderly men and women. The Cardiovascular Health Study. JAMA 1993;269(21):27418.
Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005;128(4):2068-75.
Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272(19):1497-505.
Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc. 2005;2(1):8-11.
Albalak R, Frisancho AR, Keeler GJ. Domestic biomass fuel combustion and chronic bronchitis in two rural Bolivian villages. Thorax 1999;54(11):1004–8
Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003;22(3):462–9
Chiba H, Abe S. The environmental risk factors for COPD tobacco smoke, air pollution, chemicals. Nihon Rinsho 2003;61(12):2101–6
Leberl M, Kratzer A, Taraseviciene-Stewart L. Tobacco smoke-induced COPD/emphysema in the animal model - are we all on the same page? Front Physiol. 2013;4:91.
Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-46.
oriano JB, Rigo F, Guerrero D, Yanez A, Forteza JF, Frontera G, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest 2010;137(2):333–40.
Roversi S, Roversi P, Spadafora G, Rossi R, Fabbri LM. Coronary artery disease concomitant with chronic obstructive pulmonary disease. Eur J Clin Invest 2014;44(1):93–102
Abbasi IN, Ahsan A, Nafees AA. Correlation of respiratory symptoms and spirometric lung patterns in a rural community setting, Sindh, Pakistan: a cross-sectional survey. BMC Pulm Med 2012;12:81.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan Journal of Chest Medicine

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.